Journal
JOURNAL OF AAPOS
Volume 7, Issue 1, Pages 69-70Publisher
MOSBY, INC
DOI: 10.1016/S1091-8531(02)42013-7
Keywords
-
Categories
Ask authors/readers for more resources
Brimonidine is a selective alpha-2 adrenergic agonist used to treat glaucoma. There have been several reports of central nervous system depression after its use in infants. (1-4) We observed rapid-onset bradycardia and decreased blood pressure in addition to central nervous system depression in 2 infants who received concomitant topical brimonidine and beta-blockers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available